A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Clinical trial NCT06770933 · RECRUITING
Trial details
- NCT number
- NCT06770933
- Sponsor
- Vantage Biosciences Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2027-03-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.